Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate
Authors:
- Noriyuki TatsumiNTNoriyuki Tatsumi
- Masami HiranoMHMasami Hirano
- Kuniyuki ImaiKIKuniyuki Imai
- Hideaki MizoguchiHMHideaki Mizoguchi
- Tohru NakamuraTNTohru Nakamura
- Masaaki KosakaMKMasaaki Kosaka
- Kiyoshi TakatsukiKTKiyoshi Takatsuki
- Toshihiko YamayaTYToshihiko Yamaya
- Keisuke ToyamaKTKeisuke Toyama
- Takashi YoshidaTYTakashi Yoshida
- Tohru MasaokaTMTohru Masaoka
- 1 January 1991
- journal article
- clinical trial
- Published by S. Karger AG in Oncology
- Vol. 48 (6) , 451-455